Search Results 131-140 of 17147 for Paroxetine

  1. Anxiety Disorders Clinical Trials - Mayo Clinic Research

    This study examines Stress Management and Resilience Training (SMART) for family caregivers (FCG) of patients receiving chemotherapy for advanced cancer to ...

  2. Phenytoin (injection route) - Mayo Clinic

    Paroxetine; Phenprocoumon; Piperine; Progabide; Quinine; Remacemide; Rufinamide; Sabeluzole; Shankhapulshpi; Sirolimus; Sulthiame; Telithromycin; Tenidap ...

  3. SNRIs ease depression by affecting chemical messengers called neurotransmitters that affect mood. SNRIs block the reabsorption, also called reuptake, ...

  4. Depression (major depressive disorder) - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  5. Selective Serotonin Inhibitor-Induced Changes in the Gut Microbiome in Depression - Mayo Clinic

    The purpose of this study is to uncover the main effects of selective serotonin inhibitor-induced (SSRI) therapy on the human microbiota, the relationship to ...

  6. People with depression are at an increased risk of suicide. If a person is severely depressed, they may feel suicidal at some point. Take all signs of suicidal ...

  7. Generalized anxiety disorder - Doctors and departments - Mayo Clinic

    Excessive, ongoing anxiety and worry can interfere with your daily activities and may be a sign of generalized anxiety disorder, but treatment can help.

  8. EDIT&RES Trial - Mayo Clinic

    The purpose of this study is to investigate the association between changes in adenosine-to-inosine (A-to-I) RNA editing and changes in depression severity, as ...

  9. Effectiveness of Deep Brain Stimulation for Treating People with Treatment Resistant Obsessive-Compulsive Disorder - Mayo Clinic

    ... paroxetine, citalopram, escitalopram, clomipramine) for at least 3 months at the maximum tolerated dose. These trials may include any of the agents above ...

  10. Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through the Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast - Mayo Clinic

    The potent inhibitors of tamoxifen metabolism are: bupropion, cinacalcet, fluoxetine, paroxetine, quinidine. Prior use of SERMS or AIs including tamoxifen ...